These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3710629)

  • 21. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
    Weiss P; Halkin H; Almog S
    Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromium-51-EDTA clearance in adults with a single-plasma sample.
    Mårtensson J; Groth S; Rehling M; Gref M
    J Nucl Med; 1998 Dec; 39(12):2131-7. PubMed ID: 9867156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
    Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
    Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of erythromycin on the disposition kinetics of warfarin.
    Bachmann K; Schwartz JI; Forney R; Frogameni A; Jauregui LE
    Pharmacology; 1984; 28(3):171-6. PubMed ID: 6718483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection.
    Chen Q; Tan E; Strauss JR; Zhang Z; Fenyk-Melody JE; Booth-Genthe C; Rushmore TH; Stearns RA; Evans DC; Baillie TA; Tang W
    J Pharmacol Exp Ther; 2004 Oct; 311(1):307-14. PubMed ID: 15163679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.
    Jiang X; Blair EY; McLachlan AJ
    J Clin Pharmacol; 2006 Nov; 46(11):1370-8. PubMed ID: 17050802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of underlying disease on busulfan disposition in pediatric bone marrow transplant recipients: a nonparametric population pharmacokinetic study.
    Bertholle-Bonnet V; Bleyzac N; Galambrun C; Mialou V; Bertrand Y; Souillet G; Aulagner G
    Ther Drug Monit; 2007 Apr; 29(2):177-84. PubMed ID: 17417071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apparent clearance of sirolimus in heart transplant recipients: impact of primary diagnosis and serum lipids.
    Zahir H; Keogh A; Akhlaghi F
    Ther Drug Monit; 2006 Dec; 28(6):818-26. PubMed ID: 17203553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
    Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
    Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.
    Brendel K; Legrand M; Taburet AM; Baron G; Goujard C; Mentré F;
    Fundam Clin Pharmacol; 2005 Jun; 19(3):373-83. PubMed ID: 15910662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the clearance of amylobarbitone from a single plasma measurement.
    Bachmann K
    Br J Clin Pharmacol; 1987 Jan; 23(1):94-8. PubMed ID: 3814466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.
    Takada K; Levy G
    J Pharm Sci; 1980 Jan; 69(1):9-14. PubMed ID: 7354452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.